Surgiphor Us in TSA

NCT ID: NCT06601803

Last Updated: 2024-09-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

PHASE4

Total Enrollment

126 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-16

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Bacteria is occasionally present in the shoulder during shoulder arthroplasty surgery and is hypothesized to increase the risk of failure of the prosthesis. Surgiphor (sterile Povidone-Iodine) wound irrigation, is a solution used in orthopaedic surgery and other surgical fields to kill bacteria intraoperatively. The Iodine dissociates from complex and has antimicrobial properties, causing cell death of bacteria, fungi, and viruses through interactions with proteins, nucleotides, and fatty acids in the cytoplasm and cytoplasmic membrane.

This study examines the use of Povidone-Iodine during primary shoulder arthroplasty.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to determine the rate of reduction of positive cultures collected before and after wound irrigation with either Surgiphor or sterile normal saline during primary total shoulder arthroplasty

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Total Shoulder Arthroplasty Shoulder Infection Povidone Iodine

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Total Shoulder Arthroplasty washed with Saline

This arm will consist of sterile normal saline to be used before and after placement of shoulder arthroplasty components

Group Type ACTIVE_COMPARATOR

sterile saline solution

Intervention Type DRUG

The shoulder will be washed with normal sterile saline before and after placing the shoulder implant

Sample Collection

Intervention Type PROCEDURE

During the surgical procedure, 4 swabs of the surgical wound will be taken at various times throughout the procedure

Total Shoulder Arthroplasty washed with Surgiphor (Povidone Iodine)

This arm will consist of Surgiphor to be used before and after placement of shoulder arthroplasty components

Group Type ACTIVE_COMPARATOR

Surgiphor

Intervention Type DRUG

The shoulder will be washed with Surgiphor (Povidone Iodine) before and after placing the shoulder implant

Sample Collection

Intervention Type PROCEDURE

During the surgical procedure, 4 swabs of the surgical wound will be taken at various times throughout the procedure

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

sterile saline solution

The shoulder will be washed with normal sterile saline before and after placing the shoulder implant

Intervention Type DRUG

Surgiphor

The shoulder will be washed with Surgiphor (Povidone Iodine) before and after placing the shoulder implant

Intervention Type DRUG

Sample Collection

During the surgical procedure, 4 swabs of the surgical wound will be taken at various times throughout the procedure

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Adults age \>18 years
* Participants undergoing elective primary total shoulder arthroplasty
* Participants willing to provide written consent

Exclusion Criteria

* History of prior surgery to the operative shoulder
* Known allergy to povidone iodine, iodine or shellfish
* active clinical infection
* participation in other clinical trials
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Rothman Institute Orthopaedics

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Rothman Orthopaedic Institute

Philadelphia, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

SNAM20D1057

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Approach to Shoulder Instability
NCT02060227 COMPLETED NA
Results of Rotator Cuff Repair
NCT01549912 COMPLETED